Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed), beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | polymerase (DNA directed), beta | 335 aa | 303 aa | 32.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | glutamate receptor 2 | 0.0216 | 0.1614 | 0.1614 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Mycobacterium ulcerans | glutaminase | 0.033 | 0.3166 | 1 |
Echinococcus multilocularis | glutamate receptor 2 | 0.027 | 0.2343 | 0.2343 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0262 | 0.2246 | 0.2246 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.3636 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0316 | 0.2975 | 0.2975 |
Brugia malayi | Glutamate receptor 1 precursor | 0.0242 | 0.197 | 0.5262 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0641 | 0.2024 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.0202 | 0.1426 | 0.1426 |
Brugia malayi | Glutamate receptor 2 precursor | 0.0242 | 0.197 | 0.5262 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.027 | 0.2343 | 0.2343 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.1161 | 0.3668 |
Echinococcus multilocularis | glutamate receptor subunit protein glur | 0.0151 | 0.0729 | 0.0729 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0173 | 0.1026 | 0.1026 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2096 | 0.5763 |
Loa Loa (eye worm) | glutaminase | 0.033 | 0.3166 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0173 | 0.1026 | 0.1026 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 0.3166 | 1 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.027 | 0.2343 | 0.2343 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0365 | 0.3636 | 1 |
Brugia malayi | glutaminase DH11.1 | 0.033 | 0.3166 | 1 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0435 | 0.4589 | 0.4211 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0365 | 0.3636 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0173 | 0.1026 | 0.1026 |
Echinococcus granulosus | nmda type glutamate receptor | 0.029 | 0.2619 | 0.2619 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0262 | 0.2246 | 0.2246 |
Loa Loa (eye worm) | glutamate receptor 2 | 0.0145 | 0.0653 | 0.2062 |
Echinococcus granulosus | glutamate receptor 2 | 0.027 | 0.2343 | 0.2343 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 0.3166 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2096 | 0.6621 |
Echinococcus granulosus | glutamate receptor subunit protein glur | 0.0151 | 0.0729 | 0.0729 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.029 | 0.2619 | 0.2619 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0173 | 0.1026 | 0.1026 |
Onchocerca volvulus | 0.0286 | 0.2568 | 1 | |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0173 | 0.1026 | 0.1026 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0242 | 0.197 | 0.197 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0173 | 0.1026 | 0.1026 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0641 | 0.2024 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.3636 | 1 |
Brugia malayi | hypothetical protein | 0.0182 | 0.1161 | 0.206 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0202 | 0.1426 | 0.0827 |
Loa Loa (eye worm) | glutamate receptor 1 | 0.0242 | 0.197 | 0.6221 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0316 | 0.2975 | 0.2975 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.0202 | 0.1426 | 0.1426 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0192 | 0.1292 | 0.5 |
Schistosoma mansoni | glutaminase | 0.033 | 0.3166 | 0.2689 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0216 | 0.1614 | 0.1614 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 23.9341 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | = 79.4328 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.